quantitative models. Ann Intern Med 1994; 120: 799-805.
17. Jinich H. Ciencia, tecnología y humanismo en Medicina. Gac Méd Méx 1990; 126: 481-6.
18. Viniegra L. El fetichismo de la tecnología. Rev Invest Clín 2000; 52: 569-80.
19. Narayan KM, Gregg EW, Engelgau MM, Moore B, Thompson TJ, Williamson DE, Vinicor F. Translation Research for Chronic disease. The case of diabetes. Diabetes Care 2000; 23: 794-8.
20. Kraus A. Carpe diem, una paciente crónica. Nexos, octubre 2001: 91-4.
21. Latapí P. Medicina, crisis profesional o crisis humana. Gac Méd Méx 1979; 115: 151-6.
22. The Editors. Looking back in the millennium in medicine. N Engl J Med 2000; 342(1): 42-9.
23. Feinstein AR. Twentieth century paradigms that threaten both scientific and human medicine in the twenty first century. J Clin Epidemiol 1996; 49: 615-7.
24. Charlton BG. The scope and nature of epidemiology. J Clin Epidemiol 1996; 49: 623-6.
25. Benítez BL. Evidence based medicine. A new paradigm? Arch Med Res 1999; 30; 77-9.
26. Bradford HA. Principles of medical statistics. 9th Ed. Lancet. London 1971.
27. Skrabanek P. The epidemiology of errors. Lancet 1993; 342: 1502.
28. Skrabanek P. The death of human medicine (and the rise of coercive healthism). Sufolk, England. Social affairs unit. St Edmundsbury Press; 1994.
29. López JF, Lamas GA. Evidence based medicine. Arch Med Res 1999; 30: 80-1.
30. Hostetter TH. Prevention of end stage renal disease to type 2 diabetes. N Engl J Med 2001; 345; 910-1.
31. Ravnsov U. Cholesterol lowering trials in coronary heart disease; frequency of citation and outcome. Br Med J 1992; 305: 15-9.
32. McCormick James. Medical hubris and the public health. The ethical dimension. J Clin Epidemiol 1996; 49: 619-21.
33. Jeffery RW. Population perspectives on the prevention and treatment of obesity in minority populations. Am J Clin Nutr 1999; 53: 1621S-24S.